Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
LONDON, Aug 10 (Reuters) - Booster shots for COVID-19 vaccines are not currently needed and the doses should be given to other countries, Oxford vaccine chief Andrew Pollard said on Tuesday in contrast to the position taken by Britain's health mi...
Read more(Adds changes to estimates, details on Pfizer)By Ludwig BurgerFRANKFURT, Aug 9 (Reuters) - BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor...
Read more(Adds rationale on third shot)By Ludwig BurgerFRANKFURT, Aug 9 (Reuters) - BioNTech said that repeat shots of its COVID-19 vaccine, of which more than a billion doses have now been supplied worldwide, was a better strategy than tailoring the produ...
Read moreFRANKFURT, Aug 9 (Reuters) - BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca, the German biotech group said on Monday.AstraZe...
Read more
LONDON BROKER RATINGS: Liberum says buy Made.com; RBC cuts ConvaTec
Read moreLONDON MARKET OPEN: Hargreaves Lansdown falls on higher costs warning
Read moreAstraZeneca's Forxiga gets EU approval for kidney disease treatment
Read moreLONDON BRIEFING: HL pays special dividend after "extraordinary" year
Read more
(Sharecast News) - AstraZeneca announced on Monday that 'Forxiga', or dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, has been approved in the European Union for the treatment of chronic kidney disease (CKD) in adults with and without type-2 diabetes.
Read more(Adds J&J statement in sixth paragraph)By Pushkala AripakaAug 6 (Reuters) - No causal link between COVID-19 vaccines and menstrual disorders has been found so far, Europe's drugs regulator said on Friday, separately recommending that three new co...
Read more(Writes through with detail, background)By Pushkala AripakaAug 6 (Reuters) - No causal link between COVID-19 vaccines and menstrual disorders has been found so far, Europe's drugs regulator said on Friday, separately recommending that three new c...
Read more(Corrects paragraph 4 to show protection rates are against hospitalisation, not infection.)JOHANNESBURG, Aug 6 (Reuters) - Johnson & Johnson's COVID-19 vaccine is working well in South Africa, offering protection against severe disease and death, ...
Read more(Corrects paragraph 4 to show protection rates are against hospitalisation, not infection.)JOHANNESBURG, Aug 6 (Reuters) - Johnson & Johnson's COVID-19 vaccine is working well in South Africa, offering protection against severe disease and death, ...
Read more(Adds health minister comments on AstraZeneca and Sinovac)JOHANNESBURG, Aug 6 (Reuters) - Johnson & Johnson's COVID-19 vaccine is working well in South Africa, offering protection against severe disease and death, the co-head of a trial in the cou...
Read more
Last checked at